Overview
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Eligibility
Inclusion Criteria:
- Known or suspected colorectal adenocarcinoma (Stage I to IV disease)
- Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent.
- 18 years old or older
- Willing and able to provide informed consent
- Willing to have additional blood samples collected during routine surveillance visits
Exclusion Criteria:
- Not willing to have additional blood samples collected
- Pathology that is not consistent with colorectal adenocarcinoma